Product photo 1 of 21 / 2

Retatrutide

Retatrutide (LY3437943) is a synthetic, lipidated 39-amino-acid peptide based on the GIP sequence, characterized as an agonist at the GIP, GLP-1 and glucagon receptors. Supplied as a lyophilized research reference material with lot-specific, independently tested documentation.

Select Vial
$260.00

Out of stock

Retatrutide—
$260.00

For research use only. Not for human or veterinary use.

Chemical information

Vial content
60 mg, 30 mg per vial
Compound
Retatrutide
Also known as
LY3437943
Classification
Synthetic lipidated peptide; GIP, GLP-1 and glucagon receptor agonist
Sequence
Y-Aib-QGTFTSDYSI-(α-Me-Leu)-LDK-K*-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂ (Aib = 2-aminoisobutyric acid; K* = Lys acylated with C20 diacid–γGlu–AEEA)
Length
39 amino acids
Molecular formula
C₂₂₁H₃₄₂N₄₆O₆₈
Molecular weight
4731.3 g/mol
CAS number
2381089-83-2
Form
Lyophilized (freeze-dried) powder
Storage
Store lyophilized at −20 °C, sealed and protected from light and moisture. Allow the vial to reach room temperature before opening.

Chemical information is for identification and reference. Formula and weight are for the free peptide or compound; the supplied salt form (e.g. acetate) may differ. The lot's certificate of analysis is the reference for the material you receive.

Testing & documentation

Every lot is tested independently by Finnrick before release for identity, purity, quantity, endotoxins and heavy metals. The current lot's certificate of analysis is linked above, and any lot number can be checked on the COA & lot lookup page.

How we test every lot

Shipping & sales policy

Ships by USPS Ground Advantage or Priority Mail to street addresses in the 50 states and DC. No PO boxes, military or territory addresses.

All sales are final. If an item arrives wrong or damaged, or your package is lost, report it from your account within 7 days and we'll reship or refund.

Research use only

For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes. See our research-use policy.